Name: 

David J. P. FitzGerald

 

Education: 

    1977 B.A.  -- Trinity College, University of Dublin, Ireland;
                            Moderatorship in Microbiology, Second class
                            honors, first division.

    1982 Ph.D. -- University of Cincinnati, College of Medicine,
                            Department of Microbiology.

Brief chronology of employment: 

    1982-1984    -- Staff Fellow, Laboratory of Molecular Biology,
                                National Cancer Institute, National Institutes
                                of Health

    1985-1987    -- Senior Staff Fellow, Laboratory of Molecular
                                Biology, National Cancer Institute, NIH

    1987-1994    -- Microbiologist, (Senior Investigator)
                                Laboratory of Molecular Biology, National
                                Cancer Institute, NIH

    1994-present -- Chief, Biotherapy Section, Laboratory of Molecular
                                Biology, National Cancer Institute, NIH

Editorial boards: 

    Infection and Immunity (1987-1989)
    Journal of National Cancer Institute (1990-1994)
    Journal of Pharmaceutical Sciences
    Journal of Bioconjugate Chemistry (1990-1994)
    Journal of Drug Targeting
    Therapeutic Immunity
    Journal of Biological Chemistry (1996-present)

Societies: 

    AAAS
    American Society for Biochemistry and Molecular Biology
    American Association for Cancer Research

Other special scientific recognition: 

    Chairman of Gordon Conference (1994)
    Assisted with planning of DAHLEM Conference (Nov. 1989), Berlin

Patents: 

    Pastan, I., Willingham, M.C., and FitzGerald, D.J.:  Pseudomonas
              exotoxin conjugate immunotoxins.  (Assignee:  U.S.A., D.H.H.S.)
              (Filed January 26, 1984.)  Granted U.S. Patent #4,545,985,
              October 8, 1985.

    Pastan, I., FitzGerald, D.J.P., and Willingham, M.C.: Monoclonal
              antibody against ovarian cancer cells (OVB3).  Patent
              #4,806,494, February 21, 1989.

    Pastan, I., Adhya, S., and FitzGerald, D.J.P.:  Recombinant
              Pseudomonas Exotoxin,:  Construction of an active immunotoxin
              with low side effects.  Patent # 4,892,827, January 9, 1990.

Go to:

  Top of Page
  Research Information 
  Laboratory of Molecular Biology 
  National Cancer Institute 
  National Institutes of Health